Amgen Hid IRS' $10B Tax Dispute, Shareholder Suit Alleges
By Katryna Perera · March 14, 2023, 11:25 PM EDT
Biotech company Amgen Inc. was hit with a securities class action alleging the company hid years of reports, adjustments and deficiency notices from the Internal Revenue Service, which led to artificially inflated...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login